Progyny Analyst Price Targets - Benzinga

Progyny Inc

PGNYNASDAQ

Trade with Public

Trade with Public

$27.08

1.144.39%

Dern. MÀJ: Sep 8, 12:23 PM

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Progyny Analyst Price Targets

Wall Street analyst price targets and consensus rating for Progyny (PGNY).

Price Target Range — 13 Quarters

Analyst Consensus — 12 Analysts

1S.Buy

9Buy

2Hold

Consensus RatingOverweight# Analysts12Avg. Consensus PT$31Upside to Avg. PT+15.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 8, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$31→$33
Aug 21, 2026	JP Morgan	Lisa Gill	PT Raise	Neutral	$27→$30
Aug 20, 2026	Wells Fargo	Stan Berenshteyn	Initiate	Overweight	$37
Aug 13, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$33→$36
Aug 12, 2026	Barclays	Peter Warendorf	PT Cut	Equal-Weight	$34→$30
Jul 28, 2026	Barclays	Peter Warendorf	Downgrade	Overweight→Equal-Weight	$27→$34
Jul 24, 2026	BTIG	David Larsen	PT Raise	Buy	$30→$40
Jul 21, 2026	Canaccord Genuity	Richard Close	PT Raise	Buy	$30→$36
Jul 13, 2026	Keybanc	Scott Schoenhaus	PT Raise	Overweight	$30→$35
Jun 22, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$30→$33
Jun 2, 2026	B of A Securities	Michael Cherny	PT Raise	Buy	$29→$31
May 19, 2026	Canaccord Genuity	Richard Close	Upgrade	Hold→Buy	$19→$30
May 18, 2026	Barclays	Glen Santangelo	PT Raise	Overweight	$23→$27
May 11, 2026	Truist Securities	Jailendra Singh	PT Raise	Buy	$28→$30
May 11, 2026	Citizens	Constantine Davides	PT Raise	Market Outperform	$30→$31
Mar 20, 2026	Barclays	Glen Santangelo	PT Cut	Overweight	$29→$23
Mar 11, 2026	Canaccord Genuity	Richard Close	PT Cut	Hold	$26→$19
Mar 5, 2026	BTIG	David Larsen	PT Cut	Buy	$35→$30
Mar 2, 2026	Keybanc	Scott Schoenhaus	PT Cut	Overweight	$32→$28
Mar 2, 2026	Truist Securities	Jailendra Singh	PT Cut	Buy	$34→$28

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Citizens Maintains Market Outperform on Progyny, Raises Price Target to $33

Citizens analyst Constantine Davides maintains Progyny (NASDAQ:PGNY) with a Market Outperform and raises the price target from $31 to $33.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30

JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $27 to $30.

Benzinga Newsdesk

PRO
Wells Fargo Initiates Coverage On Progyny with Overweight Rating, Announces Price Target of $37

Wells Fargo analyst Stan Berenshteyn initiates coverage on Progyny (NASDAQ:PGNY) with a Overweight rating and announces Price Target of $37.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Progyny, Raises Price Target to $36

Truist Securities analyst Jailendra Singh maintains Progyny (NASDAQ:PGNY) with a Buy and raises the price target from $33 to $36.

Benzinga Newsdesk

PRO
Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30

Barclays analyst Peter Warendorf maintains Progyny (NASDAQ:PGNY) with a Equal-Weight and lowers the price target from $34 to $30.

Benzinga Newsdesk

This Clorox Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Wall Street analysts change outlook on top stocks. See upgrade, downgrade, and initiation changes on our analyst ratings page. CLX stock has mixed reviews.

Avi Kapoor